Obstetrics & Gynecology Hospital Of Fudan University

This study is testing whether combining three drugs—paclitaxel (or nab-paclitaxel), pembrolizumab, and mirabegron—can help control recurrent ovarian cancer. It aims to see if this combination shrinks tumors and is safe for patients. The trial will involve about 20 adults whose ca…

This early-phase study is testing the safety and initial effectiveness of a new, personalized treatment for advanced gynecologic cancers. The treatment involves collecting a patient's own immune cells, growing tumor-fighting versions of them in a lab, and injecting them back alon…

This study aims to track nearly 1,500 patients in China who have had a molar pregnancy (a non-viable pregnancy with abnormal tissue growth). The goal is to understand how often this condition turns into cancer and to learn more about why this happens. Researchers will collect med…